These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 38173044)
1. Exploring the prognostic potential of m6A methylation regulators in low-grade glioma: implications for tumor microenvironment modulation. Wu H; Chen S; Hu Z; Ge R; Ma L; You C; Huang Y Eur J Med Res; 2024 Jan; 29(1):19. PubMed ID: 38173044 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of tumor microenvironment and m6A RNA methylation regulators and its effects on PD-L1 and immune infiltrates in cervical cancer. Ji H; Zhang JA; Liu H; Li K; Wang ZW; Zhu X Front Immunol; 2022; 13():976107. PubMed ID: 36091006 [TBL] [Abstract][Full Text] [Related]
4. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment. Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566 [TBL] [Abstract][Full Text] [Related]
5. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma. Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X Front Genet; 2022; 13():872186. PubMed ID: 35937991 [No Abstract] [Full Text] [Related]
6. Characterization of the Clinical Significance of PD-1/PD-Ls Expression and Methylation in Patients With Low-Grade Glioma. Mei J; Cai Y; Xu R; Yang X; Zhou W; Wang H; Liu C Technol Cancer Res Treat; 2021; 20():15330338211011970. PubMed ID: 33955303 [TBL] [Abstract][Full Text] [Related]
7. M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer. Liu X; Ma C; Liu H; Sun Z; Luo J J Cancer Res Clin Oncol; 2022 Oct; 148(10):2803-2814. PubMed ID: 35596010 [TBL] [Abstract][Full Text] [Related]
8. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma. Li R; Chen H; Li C; Qi Y; Zhao K; Wang J; You C; Huang H BMC Bioinformatics; 2023 Jul; 24(1):274. PubMed ID: 37403043 [TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment. Shi Y; Wang Y; Zhang W; Niu K; Mao X; Feng K; Zhang Y Front Endocrinol (Lausanne); 2023; 14():1153802. PubMed ID: 37469973 [TBL] [Abstract][Full Text] [Related]
10. Integrating m6A Regulators-Mediated Methylation Modification Models and Tumor Immune Microenvironment Characterization in Caucasian and Chinese Low-Grade Gliomas. Liu W; Li C; Wu Y; Xu W; Chen S; Zhang H; Huang H; Zhao S; Wang J Front Cell Dev Biol; 2021; 9():725764. PubMed ID: 34900988 [No Abstract] [Full Text] [Related]
11. N Li C; Zhu M; Gao C; Lu F; Chen H; Liu J; Zhong W Front Biosci (Landmark Ed); 2024 Jan; 29(1):33. PubMed ID: 38287827 [TBL] [Abstract][Full Text] [Related]
12. Expression profiles of m6A RNA methylation regulators, PD-L1 and immune infiltrates in gastric cancer. Xu Z; Chen Q; Shu L; Zhang C; Liu W; Wang P Front Oncol; 2022; 12():970367. PubMed ID: 36003776 [TBL] [Abstract][Full Text] [Related]
13. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas. Zhao WJ; Ou GY; Lin WW Front Immunol; 2021; 12():682415. PubMed ID: 34054873 [TBL] [Abstract][Full Text] [Related]
14. m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma. Du J; Ji H; Ma S; Jin J; Mi S; Hou K; Dong J; Wang F; Zhang C; Li Y; Hu S Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33594424 [TBL] [Abstract][Full Text] [Related]
15. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Acute Myeloid Leukemia. Du A; Wu X; Gao Y; Jiang B; Wang J; Zhang P; Zhao Q Front Immunol; 2021; 12():789914. PubMed ID: 34887874 [TBL] [Abstract][Full Text] [Related]
16. Identification of Critical m Zheng J; Wang X; Qiu Y; Wang M; Yu H; Zhou Z; Wu Z; Jiang X Biomed Res Int; 2021; 2021():9959212. PubMed ID: 34212046 [TBL] [Abstract][Full Text] [Related]
17. Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma. Cao Y; Zhu H; Chen Q; Huang H; Xie D; Li X; Jiang X; Ren C; Peng J Front Pharmacol; 2022; 13():914667. PubMed ID: 36091778 [No Abstract] [Full Text] [Related]
18. Identification of Implications of Angiogenesis and m6A Modification on Immunosuppression and Therapeutic Sensitivity in Low-Grade Glioma by Network Computational Analysis of Subtypes and Signatures. Li B; Wang F; Wang N; Hou K; Du J Front Immunol; 2022; 13():871564. PubMed ID: 35572524 [TBL] [Abstract][Full Text] [Related]
19. Correlation of immune phenotype with IDH mutation in diffuse glioma. Berghoff AS; Kiesel B; Widhalm G; Wilhelm D; Rajky O; Kurscheid S; Kresl P; Wöhrer A; Marosi C; Hegi ME; Preusser M Neuro Oncol; 2017 Oct; 19(11):1460-1468. PubMed ID: 28531337 [TBL] [Abstract][Full Text] [Related]
20. Establishment and Validation of a 5 m6A RNA Methylation Regulatory Gene Prognostic Model in Low-Grade Glioma. Bai Z; Wang X; Zhang Z Front Genet; 2022; 13():655169. PubMed ID: 35281815 [No Abstract] [Full Text] [Related] [Next] [New Search]